Question 1

What is Oparta used for?

Accepted Answer

Oparta is a fixed‑dose inhalation product that combines beclometasone dipropionate, an inhaled corticosteroid, with formoterol fumarate, a long‑acting β2‑agonist. It is prescribed to improve control of asthma and to maintain lung function in chronic obstructive pulmonary disease (COPD) by reducing inflammation and providing sustained bronchodilation.

Question 2

How does beclometasone dipropionate work in Oparta?

Accepted Answer

Beclometasone dipropionate binds to glucocorticoid receptors in airway epithelial cells, suppressing the release of inflammatory mediators such as cytokines and chemokines. This anti‑inflammatory action decreases airway swelling, mucus production, and hyper‑responsiveness, helping to keep the airways open and less reactive.

Question 3

What is the usual dose of Oparta?

Accepted Answer

The prescribed dose of Oparta is determined by the treating physician based on the severity of asthma or COPD, patient age, and response to therapy. Dosage instructions are individualized and should be followed exactly as written on the prescription label.

Question 4

Is Oparta safe to use during pregnancy or breastfeeding?

Accepted Answer

Safety data for Oparta in pregnancy are limited; it should only be used if the potential benefit justifies any potential risk to the fetus. Breastfeeding mothers should consult their healthcare provider, as small amounts of inhaled corticosteroid may pass into breast milk, but the clinical significance is generally considered low.

Question 5

How do I order Oparta from GNH USA?

Accepted Answer

To request Oparta, submit an enquiry on the product page at gnh-usa.com, specifying the required quantity. GNH USA works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any required import documentation.

Question 6

How does Oparta compare with other asthma inhalers?

Accepted Answer

Oparta combines an inhaled corticosteroid with a long‑acting β2‑agonist to manage chronic airway disease.

- Asthma: improves control and reduces the frequency of exacerbations. - Chronic obstructive pulmonary disease (COPD): enhances lung function and lowers the risk of flare‑ups. - Exercise‑induced bronchoconstriction: provides pre‑exercise relief of airway narrowing.

Question 7

How should Oparta be stored and handled?

Accepted Answer

Store Oparta at ambient temperature, below 25 °C, in the original packaging to protect it from moisture and direct sunlight. Keep the inhaler cap closed when not in use and avoid exposing it to extreme temperatures that could affect the dose consistency.

Question 8

How is Oparteu administered?

Accepted Answer

Oparta is delivered via a metered‑dose inhaler. The patient inhales a prescribed number of puffs, usually after shaking the device, exhaling fully, and then breathing in slowly and deeply through the mouthpiece, followed by a breath hold for a few seconds. Specific technique instructions are provided by the prescriber.

Question 9

What are the most serious risks associated with Oparta?

Accepted Answer

Serious risks include paradoxical bronchospasm, severe allergic reactions such as anaphylaxis, pneumonia, and systemic effects from prolonged corticosteroid exposure like adrenal suppression, osteoporosis, glaucoma, or cataracts. Patients should seek immediate medical attention if they experience sudden breathing difficulty, swelling, or rash.